Welcome!


Sponsored By:

 

Featured Speakers:

PLENARY SESSION 1: The burden of cancer, essential therapies and barriers to access

Thomas Gross, M.D., Ph.D.
Deputy Director of Science, NCI Center for Global Health
CLICK HERE FOR VIDEO

Expert Panel with Drs. Felicia Knaul, Bimal Dey, Leslie Lehmann, Veronika Wirtz
CLICK HERE FOR VIDEO

PLENARY SESSION 2: Strategies and opportunities for improving global access to cancer therapies

Prof. Rifat Atun, MBBS, MBA
Professor of International Health Management at Imperial College London
CLICK HERE FOR VIDEO

CLOSING KEYNOTE ADDRESS

Dr. Paul Farmer, MD, PhD
Professor of Global Health and Social Medicine, Harvard Medical School
Co-Founder of Partners In Health
CLICK HERE FOR VIDEO

In the 21st century, cancer is emerging as a growing burden of disease in low-and middle-income settings. These settings are often the least prepared to provide the complex multi-disciplinary care that patients with cancer need. As an effort of the Global Oncology (GO) Initiative, this Symposium aimed to educate students, faculty and medical trainees about the challenges of delivering medical, surgical and radiation therapy in resource-limited settings as well as potential solutions and their implementation. Featuring leaders in the field of global health, cancer care and global health-delivery, this symposium was an enlightening experience.

Symposium Objectives:

Characterizing the problem:

1. What is the burden of cancer in low and middle-income countries?
2. What are the barriers to accessing cancer therapies in low-resource settings?
3. What methodologies are used to identify and define essential therapies/medicines for the treatment of cancer? 

Developing a solution:

1. How can we draw upon lessons from the HIV/AIDS movement and access to anti-retrovirals to improve access to cancer therapies?
2. Define challenges unique to cancer care delivery.
3. Highlight the role of innovative partnerships, pricing mechanisms and non-governmental organizations in improving access to cancer care.